Invention Grant
- Patent Title: Fusion proteins
-
Application No.: US15820608Application Date: 2017-11-22
-
Publication No.: US10709766B2Publication Date: 2020-07-14
- Inventor: David Bruce Baldwin , John Michael Beals , Jonathan Wesley Day , Craig Duane Dickinson , Andrew Ihor Korytko , Gregory Alan Lazar
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Matthew T Lord
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07K14/62 ; A61K38/16 ; A61K38/26 ; C07K14/00 ; A61K38/00
Abstract:
The present invention relates to fusion proteins comprising an insulin receptor agonist fused to a human IgG Fc region through the use of a peptide linker, and the use of such fusion proteins in the treatment of diabetes. The fusion protein of the present invention has an extended time action profile and is useful for providing basal glucose control for an extended period of time.
Public/Granted literature
- US20180177851A1 FUSION PROTEINS Public/Granted day:2018-06-28
Information query
IPC分类:
